Valuation Supergenics

Stocks

Delayed BURSA MALAYSIA 11:50:01 30/12/2025 +03			5-day change	1st Jan Change
0.2500 ^MYR	+21.95%		-.--%	-

08-28	Supergenics Berhad Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-30	Supergenics Berhad Auditor Raises 'Going Concern' Doubt	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	27.44	26.04	27.44	24.77	69.41	29.11
Change	-	-5.08%	5.36%	-9.71%	180.21%	-58.07%
Enterprise Value (EV) ¹	29.58	29.55	32.12	26.86	73.89	32.5
Change	-	-0.1%	8.69%	-16.38%	175.13%	-56.01%
P/E	-12.7x	1,284x	79.3x	123x	-9.45x	-8.61x
PBR	5.03x	4.76x	5.44x	2.85x	21x	250x
PEG	-	-13x	0x	-2.5x	0x	0.2x
Capitalization / Revenue	5.34x	2.37x	2.56x	2.42x	13x	5.17x
EV / Revenue	5.76x	2.69x	3x	2.62x	13.9x	5.78x
EV / EBITDA	-16.7x	26.7x	18.3x	12.5x	-11.1x	-14.4x
EV / EBIT	-14.7x	63.9x	27.2x	17.5x	-10x	-10.5x
EV / FCF	-15.7x	-28.3x	-38.7x	-183x	-54.1x	19.2x
FCF Yield	-6.39%	-3.54%	-2.58%	-0.55%	-1.85%	5.21%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0232	0.000218	0.003718	0.001876	-0.0635	-0.029
Distribution rate	-	-	-	-	-	-
Net sales ¹	5.135	10.99	10.72	10.24	5.322	5.625
EBITDA ¹	-1.769	1.107	1.752	2.148	-6.675	-2.264
EBIT ¹	-2.013	0.4625	1.181	1.534	-7.357	-3.107
Net income ¹	-2.15	0.0203	0.3458	0.1769	-7.281	-3.366
Net Debt ¹	2.147	3.512	4.684	2.084	4.477	3.394
Reference price ²	0.2950	0.2800	0.2950	0.2300	0.6000	0.2500
Nbr of stocks (in thousands)	93,000	93,000	93,000	107,706	115,689	116,430
Announcement Date	4/30/21 A	4/29/22 A	4/28/23 A	4/30/24 A	4/30/25 A	4/30/26 A

¹MYR in Million²MYR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUPERGENICS	-	-	-	-	7.17M
WUXI APPTEC CO., LTD.	16.97x	6.42x	12.3x	1.76%	64.38B
ARGENX SE	30.57x	8.11x	26.59x	0.05%	56.16B
LONZA GROUP AG	37.32x	6.62x	19.78x	0.87%	54.16B
IQVIA HOLDINGS INC.	35.39x	3.41x	14.74x	-.--%	45.33B
BEONE MEDICINES AG	49.25x	5.68x	31.09x	-.--%	42.25B
REVOLUTION MEDICINES, INC.	-19.59x	189.6x	-20.86x	-.--%	40.78B
GENMAB A/S	47.12x	8.37x	28.08x	-.--%	33.8B
CELLTRION, INC.	31.61x	8.04x	20.91x	0.41%	32.25B
WUXI BIOLOGICS (CAYMAN) INC.	27.96x	5.9x	15.29x	-.--%	23.57B
Average	28.51x	26.90x	16.43x	0.34%	39.27B
Weighted average by Cap.	27.98x	25.56x	16.48x	0.45%